July 21, 2014: The
stock of Indoco Remedies will remain in focus on the bourses, as the
company informed the exchanges, after market hours, about receiving the
US Food & Drugs Administration’s approval for its facility in Goa.
Based on the inspection carried out by the USFDA in August 2013, Indoco
Remedies has received Establishment Inspection Report approving the
company’s sterile plant and solid dosage facility in Goa. Analysts will
be watching the developments.
July 21, 2014: The
stock of Indoco Remedies will remain in focus on the bourses, as the
company informed the exchanges, after market hours, about receiving the
US Food & Drugs Administration’s approval for its facility in Goa.